Described in plain English, on purpose. If a technology’s value can’t be explained simply, that tells us something.
vMap, an FDA‑cleared platform that applies AI to a standard 12‑lead ECG to locate the source of a patient’s arrhythmia non‑invasively. It helps electrophysiologists identify the origin of a range of arrhythmias, including atrial fibrillation, and plan and guide ablation procedures with greater speed and precision.
Physician Syndicate InvestmentNon‑invasive neuromodulation therapy for atrial fibrillation. It offers a way to treat one of the fastest‑growing heart‑rhythm conditions without catheters, surgery, or implants.
Physician Syndicate InvestmentFurther NuPulse portfolio companies will be announced here as public disclosures are made together with the companies and their teams.
Portfolio company descriptions are provided for information only and reflect the companies’ publicly shared positioning.